BEIJING: Recent studies from Thailand, Indonesia and Chile have affirmed the efficacy of a Covid-19 vaccine produced by China’s Sinovac Biotech.
A new study conducted by Thailand’s Chulalongkorn University showed that 99.49% of Thai recipients of the vaccine, known as CoronaVac, had developed antibody responses four weeks after their second shots, the Bangkok Post reported.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
